Insilico Medicine and SK Biopharmaceuticals Announce $2.5 B Neuroimmune Drug Discovery Partnership

At the BIO 2026 International Convention in Cambridge, Mass., Insilico Medicine and SK Biopharmaceuticals unveiled a res...

Read story →